BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 33678191)

  • 1. Effect on 30-day mortality and duration of hospitalization of empirical antibiotic therapy in CRGNB-infected pneumonia.
    Li R; Tang H; Xu H; Cui K; Li S; Shen J
    Ann Clin Microbiol Antimicrob; 2021 Mar; 20(1):15. PubMed ID: 33678191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Association Between Empirical Antibiotic Treatment and Mortality in Severe Infections Caused by Carbapenem-resistant Gram-negative Bacteria: A Prospective Study.
    Zak-Doron Y; Dishon Benattar Y; Pfeffer I; Daikos GL; Skiada A; Antoniadou A; Durante-Mangoni E; Andini R; Cavezza G; Leibovici L; Yahav D; Eliakim-Raz N; Carmeli Y; Nutman A; Paul M;
    Clin Infect Dis; 2018 Nov; 67(12):1815-1823. PubMed ID: 29718143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mortality burden related to infection with carbapenem-resistant Gram-negative bacteria among haematological cancer patients: a retrospective cohort study.
    Andria N; Henig O; Kotler O; Domchenko A; Oren I; Zuckerman T; Ofran Y; Fraser D; Paul M
    J Antimicrob Chemother; 2015 Nov; 70(11):3146-53. PubMed ID: 26209312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tigecycline Therapy for Nosocomial Pneumonia due to Carbapenem-Resistant Gram-Negative Bacteria in Critically Ill Patients Who Received Inappropriate Initial Antibiotic Treatment: A Retrospective Case Study.
    Wu X; Zhu Y; Chen Q; Gong L; Lin J; Lv D; Feng J
    Biomed Res Int; 2016; 2016():8395268. PubMed ID: 28044137
    [No Abstract]   [Full Text] [Related]  

  • 5. Effectiveness of tigecycline in the treatment of infections caused by carbapenem-resistant gram-negative bacteria in pediatric liver transplant recipients: A retrospective study.
    Chen F; Shen C; Pang X; Zhang Z; Deng Y; Han L; Chen X; Zhang J; Xia Q; Qian Y
    Transpl Infect Dis; 2020 Feb; 22(1):e13199. PubMed ID: 31627248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of active surveillance and infection control measures on carbapenem-resistant Gram-negative bacterial colonization and infections in intensive care.
    Karampatakis T; Tsergouli K; Iosifidis E; Antachopoulos C; Karapanagiotou A; Karyoti A; Gritsi-Gerogianni N; Tsakris A; Roilides E
    J Hosp Infect; 2018 Aug; 99(4):396-404. PubMed ID: 29792971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Active surveillance of carbapenem-resistant gram-negative bacteria to guide antibiotic therapy: a single-center prospective observational study.
    Liang Q; Chen J; Xu Y; Chen Y; Huang M
    Antimicrob Resist Infect Control; 2022 Jun; 11(1):89. PubMed ID: 35733230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology and outcome of infections with carbapenem-resistant Gram-negative bacteria treated with polymyxin B-based combination therapy.
    Crusio R; Rao S; Changawala N; Paul V; Tiu C; van Ginkel J; Chapnick E; Kupfer Y
    Scand J Infect Dis; 2014 Jan; 46(1):1-8. PubMed ID: 24206450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is surveillance for colonization of carbapenem-resistant gram-negative bacteria important in adult bone marrow transplantation units?
    Demiraslan H; Cevahir F; Berk E; Metan G; Cetin M; Alp E
    Am J Infect Control; 2017 Jul; 45(7):735-739. PubMed ID: 28214159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between antibiotic consumption and the rate of carbapenem-resistant Gram-negative bacteria from China based on 153 tertiary hospitals data in 2014.
    Yang P; Chen Y; Jiang S; Shen P; Lu X; Xiao Y
    Antimicrob Resist Infect Control; 2018; 7():137. PubMed ID: 30479750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia.
    Perez KK; Olsen RJ; Musick WL; Cernoch PL; Davis JR; Peterson LE; Musser JM
    J Infect; 2014 Sep; 69(3):216-25. PubMed ID: 24841135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic strategies and clinical outcomes for patients with carbapenem-resistant Gram-negative bacterial bloodstream infection.
    Qu J; Feng C; Li H; Lv X
    Int J Antimicrob Agents; 2021 Mar; 57(3):106284. PubMed ID: 33484833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbapenem-resistant Gram-negative bacteria: how to prioritize infection prevention and control interventions in resource-limited settings?
    Apisarnthanarak A; Hsu LY; Khawcharoenporn T; Mundy LM
    Expert Rev Anti Infect Ther; 2013 Feb; 11(2):147-57. PubMed ID: 23409821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quercetin inhibits carbapenemase and efflux pump activities among carbapenem-resistant Gram-negative bacteria.
    Pal A; Tripathi A
    APMIS; 2020 Mar; 128(3):251-259. PubMed ID: 31755586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changing Epidemiology and Decreased Mortality Associated With Carbapenem-resistant Gram-negative Bacteria, 2000-2017.
    Babiker A; Clarke LG; Saul M; Gealey JA; Clancy CJ; Nguyen MH; Shields RK
    Clin Infect Dis; 2021 Dec; 73(11):e4521-e4530. PubMed ID: 32990319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraventricular or intrathecal polymyxin B for treatment of post-neurosurgical intracranial infection caused by carbapenem-resistant gram-negative bacteria: a 8-year retrospective study.
    Hu Y; Li D; Zhang G; Dai Y; Chen M; Jiang H; Cui W
    Eur J Clin Microbiol Infect Dis; 2024 May; 43(5):875-884. PubMed ID: 38443737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic literature review and expert consensus on risk factors associated to infection progression in adult patients with respiratory tract or rectal colonisation by carbapenem-resistant Gram-negative bacteria.
    Ferrer R; Soriano A; Cantón R; Del Pozo JL; García-Vidal C; Garnacho-Montero J; Larrosa N; Rascado P; Salavert M; Pintado V; Giró-Perafita N; Badia X
    Rev Esp Quimioter; 2022 Oct; 35(5):455-467. PubMed ID: 35859521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic application of antibiotics selects extended-spectrum β-lactamase and carbapenemases producing Gram-negative bacteria in the oral cavity.
    Bratić V; Mihaljević S; Verzak Ž; Pleško E; Lukić A; Ćaćić M; Bedenić B
    Lett Appl Microbiol; 2021 Aug; 73(2):206-219. PubMed ID: 33896011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of infections caused by multidrug-resistant gram-negative bacteria in adult hospitalized patients at Siriraj Hospital.
    Chaisathaphol T; Chayakulkeeree M
    J Med Assoc Thai; 2014 Mar; 97 Suppl 3():S35-45. PubMed ID: 24772579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcome of nosocomial pneumonia caused by Carbapenem-resistant gram-negative bacteria in critically ill patients: a multicenter retrospective observational study.
    Chen CY; Yang KY; Peng CK; Sheu CC; Chan MC; Feng JY; Wang SH; Chen CM; Zheng ZR; Liang SJ; Lin YC;
    Sci Rep; 2022 May; 12(1):7501. PubMed ID: 35525867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.